Executive Summary
Cannabis Suisse Corp (CSUI) delivered QQ3 2025 results that depict a flat revenue trajectory but a materially distressed liquidity position. Reported revenue of 7,500 USD with a gross profit of 144 USD yields a thin gross margin of 1.92%. Operating activities generated a negative cash flow of 11,450 USD, and free cash flow was also negative by 11,450 USD, while cash at period-end stood at 50 USD. The company carries a substantial debt burden (total debt 2,464,884 USD; long-term debt 2,226,267 USD) and a balance sheet with total assets of 691,107 USD against liabilities of 2,537,446 USD, producing negative stockholders’ equity (-1,846,339 USD). The result is a weak liquidity profile (current ratio 0.379) and an almost non-existent cash cushion, indicating an acute refinancing and solvency risk unless a material capital event or strategic restructuring occurs.
Key Performance Indicators
QoQ: 483.07% | YoY:143.42%
QoQ: 300.00% | YoY:126.67%
Key Insights
Revenue: 7,500 USD; YoY 0.00%, QoQ 0.00%. Gross Profit: 144 USD; Gross Margin 1.92%; YoY 132.95%, QoQ 0.00%. Operating Income: -65,727 USD; Operating Margin -8.76%; YoY -4.56%, QoQ +27.97%. EBITDA: -65,727 USD; EBITDA Margin -8.76%. Net Income: 29,515 USD; Net Margin 3.94%; YoY +143.42%, QoQ +483.07%. EPS: 0.0004; Diluted 0.0001; YoY +126.67%, QoQ +300.00%. Cash flow from operations: -11,450 USD; Free cash flow: -11,450 USD. Cash at end of period: 50 USD; Cash at beginning: 4,100 USD. Balance sh...
Financial Highlights
Revenue: 7,500 USD; YoY 0.00%, QoQ 0.00%. Gross Profit: 144 USD; Gross Margin 1.92%; YoY 132.95%, QoQ 0.00%. Operating Income: -65,727 USD; Operating Margin -8.76%; YoY -4.56%, QoQ +27.97%. EBITDA: -65,727 USD; EBITDA Margin -8.76%. Net Income: 29,515 USD; Net Margin 3.94%; YoY +143.42%, QoQ +483.07%. EPS: 0.0004; Diluted 0.0001; YoY +126.67%, QoQ +300.00%. Cash flow from operations: -11,450 USD; Free cash flow: -11,450 USD. Cash at end of period: 50 USD; Cash at beginning: 4,100 USD. Balance sheet highlights: Total assets 691,107 USD; Total liabilities 2,537,446 USD; Total stockholders’ equity -1,846,339 USD. Debt metrics: Total debt 2,464,884 USD; Net debt 2,464,884 USD. Liquidity ratios: Current ratio 0.379; Quick ratio 0.379; Cash ratio 0.000161.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
7.50K |
0.00% |
0.00% |
| Gross Profit |
144.00 |
132.95% |
0.00% |
| Operating Income |
-65.73K |
-4.56% |
27.97% |
| Net Income |
29.52K |
143.42% |
483.07% |
| EPS |
0.00 |
126.67% |
300.00% |
Key Financial Ratios
operatingProfitMargin
-876%
operatingCashFlowPerShare
$-0
Management Commentary
Not available. The earnings transcript data set provided contains no entries for CSUI QQ3 2025, thus management quotes and thematic quotes could not be extracted from the data.
Forward Guidance
No formal forward guidance was published in the QQ3 2025 release data. Given the current financial trajectory—thin margins, negative operating cash flow, and a heavily leveraged balance sheet—the company faces meaningful refinancing risk and liquidity pressures in the near term. Investors should monitor: (1) debt maturity profiles and any refinancing plans or covenant relief, (2) potential asset divestitures or strategic partnerships to monetize non-core assets, and (3) any improvements in cost structure or changes in product mix that could lift gross margins. Absent a credible liquidity plan or capital infusion, the trajectory suggests continued downside risk to equity value.